Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
88.87 CHF | -0.70% | +1.73% | +4.71% |
Apr. 29 | Novartis target Morphosys multiplies losses - takeover schedule stands | DP |
Apr. 29 | Morphosys says takeover by Novartis on course after report of drug safety concern | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.71% | 200B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
-9.53% | 195B | |
-4.04% | 145B | |
-10.94% | 144B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis' Fabhalta Found to Lower Disease Marker in Kidney Disease Patients